Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 873630 LONDON, X0
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$540,273
-$95,112 QoQ
Shares Held
259,747
-0.3% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 209 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. ALLO ranks #66 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 676,247 $335,912,169
2 REGN
Regeneron Pharmaceuticals, Inc.
 382,028 $238,209,735
3 INCY
Incyte Corp
 1,307,743 $148,245,744
4 RPRX
Royalty Pharma plc
 1,224,925 $68,681,542
5 MRNA
Moderna, Inc.
 636,199 $44,553,014
6 ALNY
Alnylam Pharmaceuticals, Inc.
 115,279 $34,702,435
7 INSM
INSMED Inc
 279,961 $29,849,438
8 BMRN
Biomarin Pharmaceutical Inc
 307,543 $17,597,610

All Filings in ALLO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $540,273 259,747
2026-03-31 $635,385 260,404
2025-12-31 $202,946 148,136
2025-09-30 $116,640 94,065
2025-06-30 $111,294 98,491
2025-03-31 $118,895 81,435
2024-12-31 $147,300 69,155
2024-09-30 $146,683 52,387
2024-06-30 $104,067 44,664
2024-03-31 $241,898 54,116
2023-12-31 $143,371 44,664
2023-09-30 $51,211 16,155
2022-06-30 $131,100 11,500
2022-03-31 $258,988 28,429
2021-12-31 $249,895 16,749
2021-09-30 $695,621 27,067
2021-06-30 $1,107,356 42,460
2021-03-31 $405,950 11,500
2020-12-31 $393,996 15,610
2020-09-30 $632,245 16,766
2020-06-30 $492,430 11,500
2020-03-31 $251,534 12,939